Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Zhang

Surgery of the Hand Dallas, TX Medical Doctor

NPI 1245426329 CMS profile 996858

1801 Inwood Rd, Dallas, TX 75390

Open in the dashboard

General payments

$11,450

190 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$35,281 paid to institutions, not to them · program year 2025

Through program year 2025, Andrew Zhang of Dallas, TX is reported in the CMS Open Payments database as having received $11,450 across 190 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $35,281 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 85th percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,425 39
2024 General $2,404 42
2023 General $1,798 36
2022 General $2,114 23
2021 General $1,500 25
2020 General $331 8
2019 General $878 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Zhang
  • Surgery of the Hand median
  • Middle half of Surgery of the Hand
  • National median

In program year 2025, general payments to Andrew Zhang were reported at $2,425. Among 212 Surgery of the Hand profiles paid that year, the median was $312 and the middle half received between $111 and $999.

Show as a table
Year Andrew Zhang Surgery of the Hand median Middle half National median
2019 $878 $337 $119–$1,310 $163
2020 $331 $149 $52–$588 $114
2021 $1,500 $251 $78–$776 $132
2022 $2,114 $260 $116–$1,251 $149
2023 $1,798 $288 $113–$961 $160
2024 $2,404 $372 $125–$888 $164
2025 $2,425 $312 $111–$999 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sientra, Inc. $2,269 16 payments
  2. AxoGen $2,257 40 payments
  3. Stryker Corporation $1,051 20 payments
  4. TELA Bio, Inc. $997 21 payments
  5. Integra LifeSciences Corporation $959 21 payments
  6. DePuy Synthes Sales Inc. $936 10 payments
  7. AbbVie, Inc. $913 12 payments
  8. Innovation Technologies Inc $238 2 payments
  9. Allergan Inc. $214 9 payments
  10. Endo Pharmaceuticals Inc. $198 2 payments
  11. Other $1,417 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,978 189 payments
  2. Travel and Lodging $472 1 payment
Products named General payments · program years 2019–2025
  1. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $2,269 16 payments
  2. Avance Nerve Graft $1,389 28 payments
  3. PRIMATRIX $833 14 payments
  4. INTEGRA DERMAL REGENERATION TEMPLATE $833 14 payments
  5. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $773 11 payments
  6. TRUMATCH $702 6 payments
  7. NATRELLE SALINE-FILLED BREAST IMPLANTS $664 9 payments
  8. Integra Recon-Skin And Wound $653 9 payments
  9. Integra Recon-Skin And Wound $653 9 payments
  10. Integra Recon-Skin And Wound $653 9 payments
  11. Other $7,697 182 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

190 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery of the Hand in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record